Immunomodulatory approaches to augment phagocyte-mediated host defense for treatment of infectious diseases

Wc, Liles

doi:10.1053/srin.2001.22724

Cited by 34 publications

(20 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Other cytokines produced by monocytes and macrophages-including granulocyte colony-stimulating factor (G-CSF), macrophage colony-stimulating factor (M-CSF), and granulocyte/macrophage colony-stimulating factor (GM-CSF)-have attracted increasing attention as potential adjunctive immunomodulatory agents for the treatment of infectious diseases [49,50]; however, their over-production is associated with inflammation and tissue injury [51], and perpetuation of the inflammatory and destructive processes occurring for example in RA [52]. MA significantly inhibits the expression of the genes coding these three cytokines, again raising the possibility of therapeutic anti-inflammatory use.…”

Section: Discussionmentioning

confidence: 99%

Expression profiles of genes involved in the mouse nuclear factor-kappa B signal transduction pathway are modulated by mangiferin

Leiro

Arranz

Yáñez

et al. 2004

International Immunopharmacology

132

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Expression profiles of genes involved in the mouse nuclear factor-kappa B signal transduction pathway are modulated by mangiferin

Leiro

Arranz

Yáñez

et al. 2004

International Immunopharmacology

132

View full text Add to dashboard Cite

“…Compared with conventional antimicrobial therapy, enhancement of neutrophil microbicidal activity, in theory, has the advantage of effectiveness against a broad spectrum of even antimicrobial-resistant microbes. This approach could therefore be a successful strategy, complementing standard antimicrobial agents, for controlling serious microbial infections (4).…”

mentioning

confidence: 99%

Lysophosphatidylcholine Increases Neutrophil Bactericidal Activity by Enhancement of Azurophil Granule-Phagosome Fusion via Glycine·GlyRα2/TRPM2/p38 MAPK Signaling

Hong¹,

Kim²,

Ham³

et al. 2010

The Journal of Immunology

View full text Add to dashboard Cite

show abstract

“…[24][25][26] Rathbun et al provided the first evidence that murine (Fancc Ϫ/Ϫ ) and human (FANCC) hematopoietic cells were hypersensitive to IFN-␥ via an increase in apoptosis. 27 These results were subsequently confirmed in an independent Fancc Ϫ/Ϫ murine model in vitro and in vivo.…”

Section: Introductionmentioning

confidence: 99%

Continuous in vivo infusion of interferon-gamma (IFN-γ) enhances engraftment of syngeneic wild-type cells in Fanca–/– and Fancg–/– mice

Ciccone

Yang

et al. 2006

Blood

View full text Add to dashboard Cite

IntroductionFanconi anemia (FA) is a heterogeneous genetic disorder characterized by a progressive bone marrow aplasia, chromosomal instability, and the acquisition of malignancies. The progressive bone marrow failure in FA and the late developing myeloid malignancies account for 90% of the mortality in FA. 1 Currently, the only cure for the hematopoietic manifestations of FA is HLA-identical allogeneic bone marrow transplantation, a therapy available to only about 30% of patients. 2 Twelve FA complementation types (FANCA, FANCB, FANCC, FANCD1, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ, FANCL, and FANCM) have been identified and the cDNAs of 11 FA genes have been sequenced. [3][4][5][6][7][8][9][10] The identification of these genes raises the potential of using gene transfer technology to express the functional cDNA into autologous stem cells. The bone marrow hypoplasia commonly observed in FA patients 1 and the reduced repopulating ability of stem cells in mice containing a disruption of the murine homologue of an FA gene 11,12 led to the hypothesis that autologous, genetically-corrected stem cells would have an engraftment and proliferation advantage. However, ex vivo culture is known to reduce stem cell engraftment in both normal murine and human cells, [13][14][15] and in an initial phase 1 clinical trial in FA patients where myelopreparation was not routinely performed 16 the detection of transduced cells was low in all patients. Furthermore, the most efficient engraftment of transduced cells in the clinical FA trial was observed in a single patient who received nonlethal ionizing radiation. Collectively, these data provide rationale for considering nonmyeloablative therapy prior to transplantation of autologous genetically-corrected stem cells.FA cells exhibit increased chromosomal breaks in response to DNA-damaging agents in vitro. 3,17 Thus there is a theoretical potential of FA patients having an increased incidence for secondary malignancies following myelopreparation with genotoxic agents. Due to the low frequency of FA in the general population 18 and the high incidence of malignant predisposition of FA patients, it is difficult to fully ascertain the risk associated with the genotoxic myelopreparation regimen in patients. However, several studies suggest an increased risk for hematopoietic and nonhematopoietic secondary malignancies [19][20][21][22] after hematopoietic stem cell transplantation in FA patients. For these reasons, a nongenotoxic myelopreparative regimen would be ideal in selecting geneticallycorrected stem cells in vivo.Interferon-gamma (IFN-␥) is a nongenotoxic immunoregulatory lymphokine with a high therapeutic index 23 that has been used to treat a number of malignancies. [24][25][26] Rathbun et al provided the first evidence that murine (Fancc Ϫ/Ϫ ) and human (FANCC) hematopoietic cells were hypersensitive to IFN-␥ via an increase in apoptosis. 27 These results were subsequently confirmed in an independent Fancc Ϫ/Ϫ murine model in vitro and in vivo. 28,29 Previous work indica...

show abstract

Immunomodulatory approaches to augment phagocyte-mediated host defense for treatment of infectious diseases

Cited by 34 publications

References 0 publications

Expression profiles of genes involved in the mouse nuclear factor-kappa B signal transduction pathway are modulated by mangiferin

Expression profiles of genes involved in the mouse nuclear factor-kappa B signal transduction pathway are modulated by mangiferin

Lysophosphatidylcholine Increases Neutrophil Bactericidal Activity by Enhancement of Azurophil Granule-Phagosome Fusion via Glycine·GlyRα2/TRPM2/p38 MAPK Signaling

Continuous in vivo infusion of interferon-gamma (IFN-γ) enhances engraftment of syngeneic wild-type cells in Fanca–/– and Fancg–/– mice

Contact Info

Product

Resources

About